ESSA Pharma (NASDAQ:EPIX) reported quarterly losses of $(0.21) per share. This is a 12.5 percent increase over losses of $(0.24) per share from the same period last year.
Affirm Earnings Came In Cold: What Do Analysts Think About The Stock Now?
Affirm Holdings Inc (NASDAQ: AFRM) topped off the earnings season for “buy now, pay later” and lending stocks with a disappointing report Wednesday — a possible indicator that the upcoming reports for other stocks in the sector may be just as sour.